Rates of Breakthrough Reactions in Inpatients at High Risk Receiving Premedication Before Contrast-Enhanced CT
- PMID: 26102383
- DOI: 10.2214/AJR.14.13810
Rates of Breakthrough Reactions in Inpatients at High Risk Receiving Premedication Before Contrast-Enhanced CT
Abstract
Objective: The purpose of this study was to determine the rate of allergiclike breakthrough reactions among inpatients at high risk receiving premedication before undergoing CT with IV iodinated low-osmolality contrast material (LOCM).
Materials and methods: Inpatients (n = 1051) completing a 13-hour corticosteroid and diphenhydramine premedication regimen before LOCM-enhanced CT from January 1, 2010, through December 31, 2013, were included in the study. Breakthrough reaction rates were compared with the ordinary allergiclike reaction rate in the general population (0.6% [545/84,928]) by use of chi-square tests. Multivariate logistic regression was performed. Number needed to treat (NNT) was calculated for patients premedicated for a previous contrast reaction.
Results: Sixty percent (626/1051) of premedicated patients had had a previous reaction to iodinated contrast material, and 40% (425/1051) were premedicated for other reasons. The overall breakthrough reaction rates were 1.2% (13/1051) (p < 0.0001 vs the general population), 2.1% (13/626) for those with a previous iodinated contrast reaction (p < 0.0001), and 0% (0/425) for those premedicated for other reasons (p = 0.18). There were no severe breakthrough reactions. Younger age (p = 0.046; odds ratio, 1.03 per year; 95% CI, 1.001-1.07) and multiple indications for premedication (p < 0.0001; odds ratio, 2.7 per indication; 95% CI, 1.5-4.8) significantly increased the likelihood of a breakthrough reaction. The estimated NNTs were 69 (95% CI, 39-304) to prevent a reaction of any severity and 569 (95% CI, 389-1083) to prevent a severe reaction.
Conclusion: Patients premedicated for a previous reaction to iodinated contrast material have a breakthrough reaction rate 3-4 times the ordinary reaction rate in the general population. Patients receiving premedication for other reasons have a breakthrough reaction rate near 0%. Many patients must receive premedication to prevent one reaction.
Keywords: allergiclike reaction; contrast material; contrast reaction; corticosteroids; premedication.
Similar articles
-
Repeat contrast medium reactions in premedicated patients: frequency and severity.Radiology. 2009 Nov;253(2):372-9. doi: 10.1148/radiol.2532090465. Epub 2009 Sep 29. Radiology. 2009. PMID: 19789241
-
Intravenous Corticosteroid Premedication Administered 5 Hours before CT Compared with a Traditional 13-Hour Oral Regimen.Radiology. 2017 Nov;285(2):425-433. doi: 10.1148/radiol.2017170107. Epub 2017 Jul 26. Radiology. 2017. PMID: 28745940
-
Premedication of patients for prior urticarial reaction to iodinated contrast medium.Abdom Imaging. 2014 Apr;39(2):432-7. doi: 10.1007/s00261-013-0058-9. Abdom Imaging. 2014. PMID: 24389892
-
The Evidence for and Against Corticosteroid Prophylaxis in At-Risk Patients.Radiol Clin North Am. 2017 Mar;55(2):413-421. doi: 10.1016/j.rcl.2016.10.012. Radiol Clin North Am. 2017. PMID: 28126223 Review.
-
Allergic reactions to iodinated contrast media: premedication considerations for patients at risk.Emerg Radiol. 2013 Aug;20(4):299-306. doi: 10.1007/s10140-012-1081-9. Epub 2013 Feb 21. Emerg Radiol. 2013. PMID: 23430296 Review.
Cited by
-
Cross-reactivity in hypersensitivity reactions to contrast agents: new classification and guide for clinical practice.Eur Radiol. 2024 Dec;34(12):7583-7588. doi: 10.1007/s00330-024-10872-8. Epub 2024 Jun 27. Eur Radiol. 2024. PMID: 38937294 No abstract available.
-
Immediate hypersensitivity reactions to iodinated contrast media despite drug prophylaxis-a comparative retrospective cohort study of breakthrough reactions in Bern (Switzerland) and Seoul (South Korea).Quant Imaging Med Surg. 2024 May 1;14(5):3326-3338. doi: 10.21037/qims-23-912. Epub 2024 Apr 19. Quant Imaging Med Surg. 2024. PMID: 38720860 Free PMC article.
-
N-(2,3-dihydroxypropyl) carbamoyl side chain: a potentially significant factor for recurrent iodinated contrast medium-related adverse drug reactions.Eur Radiol. 2024 Oct;34(10):6444-6453. doi: 10.1007/s00330-024-10730-7. Epub 2024 Apr 16. Eur Radiol. 2024. PMID: 38625610
-
Giant complex pulmonary arteriovenous malformation treated with coil embolisation under general anaesthesia with a history of contrast media allergy.BMJ Case Rep. 2023 Feb 21;16(2):e254148. doi: 10.1136/bcr-2022-254148. BMJ Case Rep. 2023. PMID: 36810332 No abstract available.
-
Pharmacological Prevention of Hypersensitivity Reactions Caused by Iodinated Contrast Media: A Systematic Review and Meta-Analysis.Diagnostics (Basel). 2022 Jul 9;12(7):1673. doi: 10.3390/diagnostics12071673. Diagnostics (Basel). 2022. PMID: 35885578 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
